Skip to main content

Advertisement

Log in

Comparison of clinicopathological features in metastatic upper tract urothelial carcinoma and urothelial bladder cancer

  • Urology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Purpose

To compare the characteristics of primary tumors, sites distribution of metastases and the metastasis-free interval (MFI) between metastatic upper tract urothelial carcinoma (UTUC) and urothelial bladder cancer (UBC), and evaluate the clinicopathological factors associated with MFI.

Methods

We retrospectively reviewed 153 metastatic urothelial carcinoma patients consecutively registered at our hospital from 1997 to 2015, including 71 UTUC and 82 UBC, with a median follow-up of 18.3 months. MFI indicators were assessed by univariate and multivariate logistic regression analysis.

Results

There were significant differences in median age at metastatic disease (p = 0.016), gender (p = 0.018), primary tumor size (p = 0.003), growth pattern (p < 0.001), grade (p < 0.001) and stage (p < 0.001) between metastatic UTUC and UBC. The median MFI of UTUC was dramatically shorter than that of UBC (6.1 vs. 17.4 months, p < 0.001). Univariate analysis revealed pathological stage was the only factor associated with the MFI of UTUC. Multivariate analysis showed that primary tumor grade was an independent inferior predictor for the MFI of UBC (HR 6.384, 95 % CI 3.21–12.69, p < 0.001), while recurrence was an independent favorable factor for the MFI of UBC (HR 0.384, 95 % CI 0.18–0.82, p = 0.014).

Conclusions

Compared to metastatic UBC, the primary tumors of metastatic UTUC were more invasive and the MFI was significantly shorter. Pathological stage was the only factor associated with the MFI in UTUC, while primary tumor grade and recurrence were independent factors for the MFI of UBC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Bellmunt J, von der Maase H, Mead GM et al (2012) Randomized phase III study comparing paclitaxel/cisplatin/gemcitabine and gemcitabine/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC intergroup study 30987. J Clin Oncol 30:1107

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Catto JW, Azzouzi AR, Rehman I et al (2005) Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma. J Clin Oncol 23:2903

    Article  CAS  PubMed  Google Scholar 

  3. Roupret M, Azzouzi AR, Cussenot O (2005) Microsatellite instability and transitional cell carcinoma of the upper urinary tract. BJU Int 96:489

    Article  CAS  PubMed  Google Scholar 

  4. Sfakianos JP, Cha EK, Iyer G et al (2015) Genomic characterization of upper tract urothelial carcinoma. Eur Urol 68(6):970–977

    Article  CAS  PubMed  Google Scholar 

  5. David KA, Mallin K, Milowsky MI et al (2009) Surveillance of urothelial carcinoma: stage and grade migration, 1993–2005 and survival trends, 1993-2000. Cancer 115:1435

    Article  PubMed  Google Scholar 

  6. von der Maase H, Sengelov L, Roberts JT et al (2005) Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer. J Clin Oncol 23:4602

    Article  PubMed  Google Scholar 

  7. Genega EM, Porter CR (2002) Urothelial neoplasms of the kidney and ureter. An epidemiologic, pathologic, and clinical review. Am J Clin Pathol 117:S36

    Article  PubMed  Google Scholar 

  8. Rink M, Ehdaie B, Cha EK et al (2012) Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery. Eur Urol 62:677–684

    Article  PubMed  Google Scholar 

  9. Sasaki Y, Oi H, Oyama T et al (2013) Non-muscle invasive bladder cancer with multiple bone metastasis without local invasion: a case report. Hinyokika Kiyo 59(10):669–672

    PubMed  Google Scholar 

  10. Bochner BH, Montie JE, Lee CT (2003) Follow-up strategies and management of recurrence in urologic oncology bladder cancer: invasive bladder cancer. Urol Clin North Am 30:777

    Article  PubMed  Google Scholar 

  11. Langner C, Hutterer G, Chromecki et al (2006) Patterns of invasion and histological growth as prognostic indicators in urothelial carcinoma of the upper urinary tract. Virchows Arch 448:604

    Article  CAS  PubMed  Google Scholar 

  12. Shinagare AB, Ramaiya NH, Jagannathan JP et al (2011) Metastatic pattern of bladder cancer: correlation with the characteristics of the primary tumor. AJR Am J Roentgenol 196:117

    Article  PubMed  Google Scholar 

  13. Leber MF, Efferth T (2009) Molecular principles of cancer invasion and metastasis. Int J Oncol 34:881

    CAS  PubMed  Google Scholar 

  14. Hüsemann Y, Geigl JB, Schubert F et al (2008) Systemic spread is an early step in breast cancer. Cancer Cell 13:58

    Article  PubMed  Google Scholar 

  15. Klein CA (2009) Parallel progression of primary tumours and metastases. Nat Rev Cancer 9:302

    Article  CAS  PubMed  Google Scholar 

  16. Billis A, Schenka AA, Ramos CC et al (2001) Squamous and/or glandular differentiation in urothelial carcinoma: prevalence and significance in transurethral resections of the bladder. Int Urol Nephrol 33:631

    Article  CAS  PubMed  Google Scholar 

  17. Genega EM, Kapali M, Torres-Quinones M et al (2005) Impact of the 1998 world health organization/international society of urological pathology classification system for urothelial neoplasms of the kidney. Mod Pathol 18:11

    Article  PubMed  Google Scholar 

  18. Das AK, Carson CC, Bolick D et al (1990) Primary carcinoma of the upper urinary tract. Effect of primary and secondary therapy on survival. Cancer 66:1919

    Article  CAS  PubMed  Google Scholar 

  19. Martin JE, Jenkins BJ, Zuk RJ et al (1989) Clinical importance of squamous metaplasia in invasive transitional cell carcinoma of the bladder. J Clin Pathol 42:250

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Cheng L, Zhang S, MacLennan GT et al (2011) Bladder cancer: translating molecular genetic insights into clinical practice. Hum Pathol 42:455

    Article  CAS  PubMed  Google Scholar 

  21. Fujita K, Uemura M, Yamamoto Y et al (2015) Preoperative risk stratification for cancer-specific survival of patients with upper urinary tract urothelial carcinoma treated by nephroureterectomy. Int J Clin Oncol 20:156

    Article  PubMed  Google Scholar 

  22. Shimomura T, Ohtsuka N, Yamada H et al (2009) Patterns of failure and influence of potential prognostic factors after surgery in transitional cell carcinoma of the upper urinary tract. Int J Clin Oncol 14:213

    Article  PubMed  Google Scholar 

  23. Ruggiero RA, Bruzzo J, Chiarella P et al (2012) Concomitant tumor resistance: the role of tyrosine isomers in the mechanisms of metastases control. Cancer Res 72:1043

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Han-Zhong Li.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xie, J., Zhang, XB., Wen, J. et al. Comparison of clinicopathological features in metastatic upper tract urothelial carcinoma and urothelial bladder cancer. Int Urol Nephrol 48, 481–487 (2016). https://doi.org/10.1007/s11255-016-1214-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-016-1214-2

Keywords

Navigation